{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 10: U.S. Tax Reform - Positive But Some Near Term Concerns For Pharma Ratings","description":"Analyst Arthur Wong shares S&amp;amp;P's thoughts on potential U.S. corporate tax reform, and discuss that while it could be a long term positive for the pharmaceutical industry, there are some concerns in the period immediately following implementation, mainly around what companies would do with all that cash. ","author_name":"S&amp;P Pharma Dose","author_url":"https:\/\/www.spglobal.com\/ratings\/en\/research-insights\/podcasts\/the-sp-pharma-dose","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/14598389\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/14598389"}